logo

For the Inventor, By the Inventor

Oceanside, CA, United States of America

International Stem Cell Corporation

Calculating rank
USPTO Granted Patents = 15

% Expired Patents = 33.3



Trademarks = 1

Forward Citations = 22

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Jeffrey D Janus (8 out of 9 patents)

silverMedal Rodolfo Gonzalez (7 out of 7 patents)

bronzeMedal Russell A Kern (5 out of 6 patents)

4.  Elena S Revazova (4 out of 4 patents)

5.  Leonid N Kuzmichev (4 out of 4 patents)

6.  Ibon Garitaonandia (4 out of 4 patents)

7.  Marina V Pryzhkova (3 out of 3 patents)

8.  Nikolay Turovets (2 out of 9 patents)

9.  Maxim Poustovoitov (2 out of 2 patents)

10.  Ruslan Semechkin (2 out of 2 patents)

11.  Larisa Agapova (2 out of 2 patents)

12.  Andrey Semechkin (2 out of 3 patents)

13.  Nickolay A Turovets (1 out of 1 patent)

14.  Judy Kelleher-Andersson (0 patent)

15.  Jeremy Hammond (0 patent)


15 patents:

1. 11324778 - Parthenogenic activation of human oocytes for the production of neuronal cells (2022-05-10),
2. 11007232 - Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases (2021-05-18),
3. 10457915 - Chemical differentiation of pluripotentstem cells into retinal epithelial cells (2019-10-29),
4. 10335422 - Small molecules that promote skin regeneration (2019-07-02),
5. 10258632 - Method of prevention of neurological diseases (2019-04-16),
6. 10039794 - Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases (2018-08-07),
7. 9926529 - Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells (2018-03-27),
8. 9920299 - Patient-specific stem cell lines derived from human parthenogenetic blastocysts (2018-03-20),
9. 9375439 - Small molecules that promote skin regeneration (2016-06-28),
10. 8986995 - Methods of deriving differentiated cells from stem cells (2015-03-24),
11. 8945083 - Cell culture medium container assembly (2015-02-03),
12. 8420393 - Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension (2013-04-16),
13. 8268621 - Methods of deriving definitive endoderm cells from pluripotent parthenogenetic stem cells (2012-09-18),
14. 7935100 - Cell culture medium container assembly (2011-05-03),
15. 7732202 - Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells (2010-06-08),
Company Overview
International Stem Cell Corporation, based in Oceanside, California, is a biotechnology company focused on developing innovative stem cell-based therapies and products. The organization specializes in human stem cell research and regenerative medicine, aiming to address various medical conditions through its proprietary technologies. By leveraging its expertise in stem cell biology, the company seeks to advance therapeutic solutions and contribute to the growing field of regenerative medicine, with potential applications in numerous healthcare sectors.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

15 Patents

#10 in Oceanside, CA

#5,045 in California

#21,100 in US

#40,018 in the World

Oceanside, CA (US)
Oceanside, CA, United States of America

International Stem Cell Corporation

Forward Citations = 22

13 inventors:

goldMedal Jeffrey D Janus (8 out of 9 patents)

silverMedal Rodolfo Gonzalez (7 out of 7 patents)

bronzeMedal Russell A Kern (5 out of 6 patents)

4.  Elena S Revazova (4 out of 4 patents)

5.  Leonid N Kuzmichev (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: International Stem Cell Corporation. Retrieved from https://idiyas.com/company/international-stem-cell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…